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Abstract
Objective: The aim of this study was to compare the effectiveness of percutaneous needle aspiration
(PNA) and percutaneous catheter drainage (PCD) in the management of liver abscess.
Methods: Electronic searches (Cochrane Library, MEDLINE, EMBASE, SCIE) were conducted to identify
randomized controlled trials (RCTs) comparing PNA and PCD. A meta-analysis was subsequently
performed.
Results: A total of five RCTs covering 306 patients were included. The meta-analysis showed that
outcomes in patients treated with PCD were superior to those in patients treated with PNA in terms of
success rate [relative risk (RR): 0.81, 95% confidence interval (CI) 0.66–0.99; P = 0.04], clinical improve-
ment [standardized mean difference (SMD): −0.73, 95% CI 0.36–1.11; P = 0.0001] and days to achieve a
50% reduction in abscess cavity size (SMD: −1.08, 95% CI 0.64–1.53; P < 0.00001). No significant
differences were found in duration of hospitalization (mean difference: −0.17, 95% CI −2.10 to 1.75;
P = 0.86) or procedure-related complications (RR: 0.50, 95% CI 0.10–2.63; P = 0.41). Days to achieve the
total or near total resolution of the abscess cavity and mortality were not calculated because data in the
RCTs in the meta-analysis were insufficient.
Conclusions: Both PNA and PCD are safe methods of draining liver abscesses. However, PCD is more
effective than PNA because it facilitates a higher success rate, reduces the time required to achieve
clinical relief and supports a 50% reduction in abscess cavity size. However, among successfully treated
patients, the outcomes of PNA are comparable with those of PCD.
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Introduction
Liver abscess is a common clinical problem in tropical countries
and is most commonly caused by pyogenic, amoebic or mixed
infections.1 Less commonly, the infection causing a liver abscess
may be fungal in origin.
For amoebic liver abscesses (ALAs), the primary treatment is
medical; however, 15% of amoebic abscesses may be refractory to
medical therapy and 20% of ALAs may be complicated by second-
ary bacterial infection.2,3 In the past, surgical drainage was the
traditional mode of treatment in such patients and in patients
with pyogenic liver abscesses (PLAs).4 However, this type of
drainage was associated with remarkably high (10–47%) morbid-
ity and mortality rates.5
Over the last two decades, outcomes in patients presenting with
liver abscesses have improved as a result of advances in radiologi-
cal diagnosis and percutaneous treatment options.6–8 Currently,
patients are treated with antibiotics along with percutaneous
needle aspiration (PNA) or percutaneous catheter drainage
(PCD), and surgical drainage is used only in patients who fail to
respond to such treatment.9,10
Previous studies have shown both PNA and PCD to be effective
and safe,11,12 although the optimal treatment remains unclear.13,14
The aim of this study was to perform a systematic review and
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meta-analysis of randomized controlled trials (RCTs) comparing
the effectiveness of PNA and PCD in the management of liver
abscesses.
Materials and methods
Search strategy and study selection
A systematic literature search was performed as shown in Table 1.
No language restriction was imposed. The citations within the
reference lists of the articles identified were subsequently searched
manually to identify additional eligible studies.
Screenings of titles, abstracts and full-text articles were com-
pleted by two authors (YC and CY). Any discrepancies were
resolved by consultation with a third author (XX).
Inclusion and exclusion criteria
Studies were required to meet the following criteria: (i) the study
design must be that of an RCT; (ii) outcomes of PNA and PCD in
the management of liver abscesses must be compared, and (iii) at
least one outcome must be reported. The type of abscess was not
restricted and thus amoebic, pyogenic, mixed and indeterminate
abscesses were included. If two studies were found to overlap, the
publication which provided data on more types of abscess was
selected. Articles were excluded if they failed to fulfil any of these
criteria.
Data extraction
Two authors (JL and JZ) independently extracted and confirmed
the data and entered them into an electronic data collection
form. Any disagreement in the two reviewers’ data collection and
quality assessment was discussed until a consensus was reached;
otherwise, a third reviewer (XX) joined the discussion as a
referee. For the validity assessment, another two authors (YC
and YL) independently assessed the methodological quality of
the included trials using the quality checklist recommended by
the Cochrane Handbook for Systematic Reviews of Interventions.15
The assessment referred to six domains: (i) random sequence
generation; (ii) allocation concealment; (iii) blinding of partici-
pants and personnel; (iv) blinding of outcome assessment; (v)
addressing of incomplete outcome data, and (vi) selective
reporting. Following the evaluation of these domains, an
included trial was judged as being at low risk for bias if it was
evaluated as ‘low’ in all domains. If the risk for bias was judged
to be ‘unclear’ or ‘high’, the trial was listed under the group of
trials with ‘high risk for bias’.
Outcomes and definitions
In this report, data for the following outcomes were extracted:
success rate; duration of hospital stay; procedure-related compli-
cations; days to achieve clinical improvement; days to achieve a
Table 1 Search strategies used to identify studies comparing the outcomes of percutaneous needle aspiration (PNA) and percutaneous
catheter drainage (PCD) in the management of liver abscess
Databases Period of search Search strategies
Cochrane
Library
To 30 April 2014 1 MeSH descriptor Liver Abscess – explode all trees
2 ‘liver abscess*’ OR ‘hepatic abscess*’
3 1 OR 2
4 needles OR catheterization OR drainage
5 3 AND 4
MEDLINE
(PubMed)
To 30 April 2014 1 Needles, catheterization, drainage [MeSH]
2 Needle aspiration OR catheter drain*
3 1 OR 2
4 (‘liver abscess*’ OR ‘hepatic abscess*’) OR ‘Liver Abscess[MeSH]’
5 (randomized controlled trial [pt] OR controlled clinical trial [pt] OR randomized [tiab] OR placebo [tiab]
OR drug therapy [sh] OR randomly [tiab] OR trial [tiab] OR groups [tiab]) NOT (animals [mh] NOT
humans [mh])
6 3 AND 4 AND 5
EMBASE
(OvidSP)
To 30 April 2014 1 (liver abscss. af.) OR (exp liver abscess*/) OR (exp hepatic abscess*/)
2 (exp needles/) OR (exp catheterization/) OR (exp drainage/)
3 (needles OR catheterization OR drainage).af.
4 2 OR 3
5 (random* or factorial* or crossover* or placebo*).af.
6 exp crossover procedure/ or exp double-blind procedure/ or exp randomized controlled trial/ or
single-blind procedure/
7 5 OR 6
8 1 AND 4 AND 7
SCIE To 30 April 2014 1 TS = (‘liver abscess*’ OR ‘hepatic abscess*’)
2 TS = (needles OR catheterization OR drainage)
3 TS = (random* OR blind* OR placebo* OR meta-analysis)
4 1 AND 2 AND 3
CBM To 30 April 2014 Search strategy was performed in Chinese using search terms similar to those used in MEDLINE
CBM, Chinese Biomedical Literature Database; EMBASE, Excerpta Medica Database; MEDLINE, Medical Literature Analysis and Retrieval System
Online; MeSH, Medical Subject Heading; SCIE, Science Citation Index Expanded.
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50% reduction in the size of the abscess cavity; days to achieve
total or near total resolution of the abscess cavity, and mortality.
The criteria for a successful percutaneous intervention were
defined as the adequate drainage of the abscess to achieve the
resolution of infection without the need for surgical drainage and
with the subsequent discharge of the patient from hospital.
Procedure-related complications included haemorrhage, pleural
effusion/empyema, persistent bile drainage, catheter displace-
ment, and sepsis, etc. Clinical improvement was defined as the
subsidence of fever, a normal leukocyte count and the resolution
of local signs and symptoms after successful PCD or PNA.
Statistical analysis
All statistical analyses were performed using RevMan Version 5.2
(Cochrane Collaboration, Nordic Cochrane Centre, Copenhagen,
Denmark). For dichotomous data and continuous data, respec-
tively, the risk ratio (RR) and mean difference (MD) with 95%
confidence intervals (CIs) for both were calculated. For continu-
ous outcomes with different measurement scales in different
RCTs, the standardized mean difference (SMD) with 95% CI was
calculated. Heterogeneity was described with the chi-squared test.
A P-value of < 0.1 was considered to indicate a difference of
statistical significance. The I2 statistic was used to measure the
quantity of heterogeneity. If significant heterogeneity existed, a
random-effects model was used. In the absence of significant het-
erogeneity, a fixed-effects model was adopted.15
In cases of missing data, the original investigators were con-
tacted to request further information. If there was no reply, the
analysis was performed on an intention-to-treat principle, if
applicable. Otherwise, the available-case analysis, also known as
the per-protocol (PP) analysis, was adopted. A few published clini-
cal trials reported data as the median and range or interquartile
range (IQR) rather than as the mean and standard deviation (SD).
According to the Cochrane Handbook, it was assumed that the
median was equal to the mean, and the SD represented a ratio of
the range or IQR of 1/4 or 1/1.23, respectively. Funnel plots were
used to determine reporting biases. The meta-analysis and sys-
tematic review were conducted according to the Cochrane Hand-
book for Systematic Reviews of Interventions15 and PRISMA
(preferred reporting items for systematic reviews and meta-
analyses) criteria.16
Results
Literature research and selection of studies
A detailed outline of the process of selecting studies for the meta-
analysis is shown in Fig. 1.
Five studies17–21 including a total of 306 patients, which fulfilled
all of the inclusion criteria, were considered for the analysis.
Study description and study quality
These five RCTs17–21 were published between 1998 and 2013. Trial
design is shown in Table 2.
In these five RCTs, the percutaneous treatment procedures were
performed under continuous real-time sonographic guidance
using freehand ultrasound. For PNA, a 16-G or 18-G trocar needle
was advanced into the abscess cavity and the contents were aspi-
rated in an attempt to completely evacuate the cavity. Aspiration
was repeated if there was either no clinical improvement or no
129 records identified
through database
searching
42 records representing
duplicates removed
89 records screened
16 full-text articles
assessed for eligibility
5 articles included in
meta-analysis
2 additional records identified
by screening the reference lists
of included RCTs
73 obviously
irrelevant records
excluded
11 full-text articles
excluded
PNA alone: n = 7
PCD alone: n = 1
Repeat studies: n = 1
Retrospective study: n = 1
Comparison with surgery: n = 1
Figure 1 Process of selection of studies comparing the outcomes of
percutaneous needle aspiration (PNA) and percutaneous catheter
drainage (PCD) in the management of liver abscess for inclusion in a
meta-analysis. RCT, randomized controlled trial
Table 2 Characteristics of studies comparing the outcomes of percutaneous needle aspiration (PNA) and percutaneous catheter drainage
(PCD) in the management of liver abscess
Authors Year of
study
Type of abscess
included
Size of abscess
included
Participants
(PNA/PCD)
Initial i.v. antibiotic treatment Risk for
bias
Rajak et al.17 1998 ALA and PLA All sizes 50 (25/25) Cloxacillin, gentamicin, metronidazole High
Yu et al.18 2004 PLA only All sizes 64 (32/32) Ampicillin, cefuroxime, metronidazole Low
Zerem & Hadzic19 2007 PLA only All sizes 60 (30/30) Cefazolin, gentamicin High
Singh et al.20 2009 ALA and PLA ≥ 10 cm 72 (36/36) Ceftriaxone, gentamicin, metronidazole High
Singh et al.21 2013 ALA and PLA All sizes 60 (30/30) Cefazolin, gentamicin, metronidazole High
ALA, amoebic liver abscess; PLA, pyogenic liver abscess.
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reduction in the size of the abscess cavity. For PCD, an appropri-
ately sized catheter (8-F to 14-F pigtail or drainage catheter) was
introduced into the abscess cavity using the Seldinger technique
or a single-step trocar technique.
The risk for bias is summarized in Table 3. Four RCTs had a
high risk for bias17,19–21 and one RCT had a low risk for bias.18
Outcomes
Liver abscess was found more commonly in men (male : female
ratios in PNA and PCD were 101:52 and 105:48, respectively). The
reported mean age of patients within the RCTs varied between 35
years and 50 years. In total, 84.0% of abscesses (125 treated with
PNA and 132 treated with PCD) were solitary and three RCTs
reported that 67.1% of abscesses (114/170) were located in the
right lobe of the liver. The most common symptoms were pain in
the right upper quadrant of the abdomen and fever, recorded in
219 of 306 (71.6%) patients (PNA, n = 111; PCD, n = 108) and 255
of 306 (83.3%) patients (PNA, n = 131; PCD, n = 126), respec-
tively. Of the coexisting diseases reported in three of the RCTs,18–20
diabetes was the most common (23.7%, 44 of 186 patients).
Among the five RCTs, there were no statistically significant differ-
ences between the two treatment groups with regard to any of the
present data, other clinical characteristics or laboratory results.
Success rate
All five RCTs17–21 reported the success rate (Fig. 2a). Success rates
were 77.8% (119 of 153 patients) and 96.1% (147 of 153 patients)
in the PNA and PCD groups, respectively (P = 0.041).
Duration of hospital stay
Four of the trials18–21 provided data on hospital stay (Fig. 2b).
Rajak et al.17 did not report the mean hospital stay, but suggested
no meaningful difference for the duration of hospitalization
among patients successfully treated with either technique. Two
studies reported the data as the mean ± SD20,21 and two studies
as the median (range).18,19 There was no significant difference
between the two groups.
Procedure-related complications
All five trials17–21 reported procedure-related complications
(Fig. 2c). Two studies17,19 reported six patients with minimal
complications. The remaining studies18,20,21 stated that no compli-
cations occurred. No significant difference in procedure-related
complications was observed following analysis.
Clinical improvement
The days to achieve clinical improvement were evaluated in three
RCTs17,20,21 (Fig. 2d). Rajak et al.17 reported that in patients treated
successfully, the average time required to achieve clinical relief was
similar in the two treatment groups (P > 0.05), but did not provide
the actual data. Therefore, only two studies were included for
analysis.20,21 Time to clinical improvement was significantly longer
in patients treated with PNA than in those treated with PCD.
Days to achieve a 50% reduction in abscess cavity size
Two studies reported the time required to achieve a 50% reduc-
tion in cavity size17,21 (Fig. 2e). The time required to achieve a 50%
reduction in cavity size was significantly greater in those under-
going PNA.
Days to achieve the total or near total resolution of the
abscess cavity
Two of the included RCTs17,21 reported the time required to
achieve the total or near total resolution of the abscess cavity.
Singh et al.21 found no significant difference between the two
groups (PNA, 10.1 weeks; PCD, 10.9 weeks; P = 0.454). Similar
observations were recorded by Rajak et al.17 (P > 0.05), although
the latter group did not give the specific data. Thus, only one study
provided the mean ± SD and thus these values were not calculated
in this analysis.
Mortality
Yu et al.18 reported five deaths (four in the PCD group and one in
the PNA group). All four of the patients who died in the PNA
group had an underlying malignancy and the remaining patient in
the PCD group had chronic obstructive pulmonary disease. Singh
et al.20 reported one patient, in the PCD group, who suffered
abscess rupture and died. No deaths were reported in the three
remaining RCTs.
Discussion
In the modern era of minimal invasiveness, percutaneous treat-
ment (either needle aspiration or catheter drainage) has become
Table 3 Risk for bias in studies comparing the outcomes of percutaneous needle aspiration (PNA) and percutaneous catheter drainage (PCD)
in the management of liver abscess
Studies Sequence
generation
Allocation
concealment
Blinding of participants
and personnel
Blinding of outcome
assessment
Incomplete
outcome data
Selective
reporting
Rajak et al.17 Uncertain High risk Uncertain Uncertain High risk High risk
Yu et al.18 Low risk Low risk Low risk Low risk Low risk Low risk
Zerem & Hadzic19 Low risk Low risk Uncertain Uncertain High risk High risk
Singh et al.20 Low risk Low risk Uncertain Uncertain Low risk Low risk
Singh et al.21 Low risk Low risk Uncertain Uncertain Low risk High risk
Risk for bias was classified as low, uncertain or high. The detail of each grade is referred to in the Cochrane Handbook for Systematic Reviews of
Interventions.15
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Figure 2 Forest plots resulting from the meta-analysis comparing the outcomes of percutaneous needle aspiration (PNA) with those of
percutaneous catheter drainage (PCD) for: (a) success rates; (b) duration of hospital stay; (c) procedure-related complications; (d) time to
clinical improvement (days), and (e) time to achieve a 50% reduction in abscess cavity size (days). SD, standard deviation; 95% CI, 95%
confidence interval; M-H, Mantel–Haenszel; IV, inverse variance
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the preferred method for the management of liver abscess. Previ-
ous investigations have shown that the combination of parenteral
antibiotics and image-guided percutaneous treatment is also suc-
cessful.8,14,22,23 The aim of this study was to determine which
approach is superior. The conclusions of the five RCTs differ. Yu
et al.18 recommend PNA as a first-line approach because the pro-
cedure is simple, facilitates patient comfort, and is of low cost.
Rajak et al.17 conclude that PCD is more effective than PNA.
Zerem and Hadzic19 recommend PNA only in patients with liver
abscess cavities of < 5 cm in diameter. Singh et al.20 and Singh
et al.21 hold the view that PCD represents a better treatment
option than PNA for large liver abscesses (≥10 cm in diameter).
Therefore, in the setting of diametric conclusions meta-analytical
techniques may provide evidence as to which treatment option is
superior.
Regarding the effectiveness of treatment, the current meta-
analysis showed a higher rate of success in the PCD group. This
may be a convincing argument in support of the PCD method.
Two reasons were identified to explain the lower rate of success in
the PNA group. The first concerns the number of aspiration
attempts. In the study by Rajak et al.,17 which reported the lowest
success rate (PNA: 60%) of the five RCTs, aspiration attempts were
restricted to two. However, Yu et al.18 did not limit the number of
attempts made and achieved the highest rate of success (PNA:
97%). The remaining three trials19–21 limited attempts to three and
reported success rates of 67–86%. In addition, PCD was associated
with the highest success rates (97.2–100%) except in the study by
Yu et al.18 (84.7%), in which the deaths of four (12.5%) patients
with underlying malignancies decreased the success rate. Thus,
even with repeat aspirations, the success rate of PNA remains
inferior to that achieved with PCD. In addition, a recent retrospec-
tive study revealed that decreases in success rates are associated
with subsequent aspiration attempts.24 This finding confirms the
conclusions of three of the RCTs.19–21 The second reason for the low
rate of success achieved by PNA relates to the size of the liver cavity
or the volume of the abscess. In smaller abscesses, the amount of
pus produced per day may be small and can be completely evacu-
ated by PNA. However, a larger abscess cavity produces a larger
quantity of pus, which needs to be drained continuously and is not
suitable for PNA. In the study by Zerem and Hadzic,19 the mean ±
SD longest diameter of the abscess cavity in the PNA group was
significantly greater in patients in whom PNA was unsuccessful
(97 ± 42 mm) than in patients in which it was successful (62 ±
35 mm). Rajak et al.17 also reported a larger mean volume of
abscesses (425 ml) in patients in whom PNA failed in comparison
with that in patients in whom it was successful (178 ml) (P < 0.05).
Other authors have drawn similar conclusions.20,21,24,25 Thick
viscous pus and the rapid accumulation of pus are important
causes of failure in both PNA and PCD.26 However, these factors
may affect the success of PNA more because PNA cannot provide
continuous drainage. Four of the RCTs17–19,21 included in the
current meta-analysis involved abscesses of all sizes, but the meta-
analysis still found a higher rate of success in the PCD group.
Baek et al. 13 and Giorgio et al.14 initially reported a much lower
incidence of complications with PNA than with PCD as one of the
major advantages of PNA over PCD. These results are inconsistent
with findings in the current analysis, which indicate no significant
difference between PNA and PCD. Major procedure-related com-
plications were rare in either group. Recent studies report a low
incidence of minor complications.21,24
Other advantages of PCD over PNA refer to the fact that the
former requires less time to achieve clinical improvement and a
50% reduction in the cavity size, as the current meta-analysis
shows. Percutaneous catheter drainage has the obvious advantage
of providing continuous catheterization by the placement of an
indwelling drainage catheter. Because of this, pus can be evacuated
more frequently and the abscess cavity shows a faster rate of
collapse during the initial period in patients treated with PCD.
However, the extent of this evidence is insufficient because only
two RCTs report these data.17,21 In addition, i.v. antibiotics may
play an important role in these outcomes. Unfortunately, the anti-
biotics used differed among all five RCTs.17–21 To eliminate this
confounding variable, more data from RCTs in which the use of
antibiotics is controlled are required.
Conclusions
In summary, this meta-analysis and systematic review indicates
that PCD is more effective than PNA. Further high-quality RCTs,
controlling for other factors such as the aetiology and size of
abscesses, and the use of antibiotics and other therapeutic inter-
ventions, are required.
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